CIK: 0000315157 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 9, 2021
Total Value ($000): $9,135,619 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| OBDC | OWL ROCK CAPITAL CORP | 4,035,112 | $5,108,451 | 55.9% | $6.98 | +3.4% | Common | 69121K104 |
| JNJ | JOHNSON & JOHNSON (JNJ) | 13,000,000 | $2,045,940 | 22.4% | $59.66 | +113.8% | Common | 478160104 |
| RPRX | ROYALTY PHARMA PLC | 3,958,498 | $1,981,228 | 21.7% | $49.50 | -14.3% | Common | G7709Q104 |